ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 63 filers reported holding ORCHARD THERAPEUTICS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $58,000 | -46.3% | 81,422 | 0.0% | 0.00% | – |
| Q4 2021 | $108,000 | -18.8% | 81,422 | +40.7% | 0.00% | – |
| Q3 2021 | $133,000 | -39.8% | 57,865 | +14.6% | 0.00% | – |
| Q2 2021 | $221,000 | -52.3% | 50,510 | -20.9% | 0.00% | – |
| Q1 2021 | $463,000 | +88.2% | 63,871 | +11.7% | 0.00% | – |
| Q4 2020 | $246,000 | +134.3% | 57,169 | +123.3% | 0.00% | – |
| Q3 2020 | $105,000 | -31.8% | 25,605 | 0.0% | 0.00% | – |
| Q2 2020 | $154,000 | +77.0% | 25,605 | +120.0% | 0.00% | – |
| Q1 2020 | $87,000 | -23.0% | 11,637 | +41.6% | 0.00% | – |
| Q4 2019 | $113,000 | +391.3% | 8,217 | +316.7% | 0.00% | – |
| Q3 2019 | $23,000 | 0.0% | 1,972 | +17.9% | 0.00% | – |
| Q2 2019 | $23,000 | – | 1,672 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 4,081,972 | $9,388,000 | 2.74% |
| RA Capital Management | 11,028,722 | $25,366,000 | 0.35% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $15,984,000 | 0.31% |
| Avidity Partners Management LP | 3,836,798 | $8,825,000 | 0.20% |
| Casdin Capital, LLC | 2,575,000 | $5,923,000 | 0.15% |
| Vivo Capital, LLC | 1,325,736 | $3,049,000 | 0.14% |
| Artal Group S.A. | 1,803,858 | $4,149,000 | 0.09% |
| Eversept Partners, LP | 569,581 | $1,310,036 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 374,811 | $862,000 | 0.09% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,078,315 | $2,480,000 | 0.07% |